The JAK inhibitors: do they bring a paradigm shift for the management of rheumatic diseases?
Author:
Affiliation:
1. The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
Funder
Gilead Sciences, Inc.
Daiichi-Sankyo
Astellas
Eli Lilly
Chugai
Sanofi
Abbvie
Pfizer
YL Biologics
Bristol-Myers
Glaxo-Smithkline
UCB
Mitsubishi-Tanabe
Novartis
Eisai
Takeda
Janssen
Asahi-kasei
Ono
MSD
Taisho-Toyama
Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Rheumatology
Link
http://academic.oup.com/rheumatology/article-pdf/58/Supplement_1/i1/27984855/key280.pdf
Reference10 articles.
1. Rheumatoid arthritis;Smolen;Lancet,2016
2. Recent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedside;Tanaka;J Biochem,2015
3. Janus kinase inhibitors in autoimmune diseases;O'Shea;Ann Rheum Dis,2013
4. Janus kinases to jakinibs: from basic insights to clinical practice;Gadina;Rheumatology,2019
5. Clinical efficacy of launched JAK inhibitors in rheumatoid arthritis;Taylor;Rheumatology,2019
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and Safety of Upadacitinib for Axial Spondyloarthritis: A Systematic Review and Meta-Analysis;Current Rheumatology Reviews;2024-08-19
2. A case report of systemic lupus erythematosus complicating interstitial lung disease and thickened pericardium treated with tofacitinib;Medicine;2024-07-26
3. Drug survival and change of disease activity using a second janus kinase inhibitor in patients with difficult-to-treat rheumatoid arthritis who failed to a janus kinase inhibitor and subsequent biologics;Advances in Rheumatology;2024-04-15
4. Update on the systemic management of noninfectious uveitis in children and adolescents;Survey of Ophthalmology;2024-01
5. Real-world comparative study of the efficacy of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study;Rheumatology;2023-11-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3